Navigation Links
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company Statement on the ADA Request for Independent Review of Incretin-Based Therapies
Date:6/13/2013

RIDGEFIELD, Conn. and INDIANAPOLIS, June 13, 2013 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) and Eli Lilly and Company (NYSE: LLY) support the American Diabetes Association (ADA) call for an independent review of the safety data of incretin-based therapies. At BIPI and Lilly, patient safety is our top priority, and we support ongoing efforts to further understand whether diabetes or certain diabetes treatments may affect the risk of pancreatitis and pancreatic cancer.

We welcome future discussion with the ADA to determine how best we can support this initiative and to provide a valuable contribution.

BIPI and Lilly also welcome the discussions taking place this week at the National Institute of Diabetes and Digestive and Kidney Diseases–National Cancer Institute (NIDDK-NCI) Pancreatitis, Diabetes and Pancreatic Cancer Workshop. The workshop was convened, in part, to examine the latest data on whether there is a potential risk of pancreatitis and pancreatic cancer in people with type 2 diabetes as well as those treated with drugs classified as incretin-based therapies.

About Diabetes
Approximately 25.8 million Americans1 and an estimated 371 million people worldwide2 have type 1 or type 2 diabetes. Type 2 diabetes is the most common type, accounting for an estimated 90 to 95 percent of all diabetes cases.1 Diabetes is a chronic condition that occurs when the body does not properly either produce or use the hormone insulin.3 Diabetes was estimated to cost the U.S. $245 billion in 2012.4

Boehringer Ingelheim and Eli Lilly and Company
In January 2011, Boehringer Ingelheim and Eli Lilly and Company announced an alliance in the field of diabetes that centers on three compounds representing several of the largest
'/>"/>

SOURCE Eli Lilly and Company; Boehringer Ingelheim Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Boehringer Ingelheim to Present 17 Abstracts at the Annual American Thoracic Society International Conference
2. Boehringer Ingelheim Presents Progression-Free Survival Data for Investigational Afatinib and Nintedanib in Advanced NSCLC
3. ASCO 2013: Boehringer Ingelheim to Present Data Across Multiple Cancers, Including Different Treatment Settings for Advanced NSCLC
4. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
5. Boehringer Ingelheim to Announce Pivotal Phase 3 Hepatitis C Data at the International Liver Congress
6. European Medicines Agency accepts marketing authorization application for Boehringer Ingelheim and Eli Lilly and Companys empagliflozin*, an investigational type 2 diabetes treatment
7. Boehringer Ingelheim and Eli Lilly and Company submit new drug application to FDA for empagliflozin, an investigational type 2 diabetes treatment
8. Boehringer Ingelheim Announces Interim Results Evaluating Virologic Response Rates in HCV/HIV Co-Infected Patients Treated with Faldaprevir
9. Boehringer Ingelheim Cares Foundation Launches Online Giving Report
10. Boehringer Ingelheim Presents Efficacy Data for Tiotropium in Symptomatic Asthma Patients in Relation to Allergic Status
11. Pharmaceutical Leader Boehringer Ingelheim Selects Republica as Cross-Cultural Marketing Agency
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/17/2014)... Oct. 17, 2014 With the recent ... function has come across several challenges in creating ... managing globalization.  The Medical ... dedicated to providing benchmarking and best practices across ... is a service composed of three stages: 1) ...
(Date:10/17/2014)...  Amgen (NASDAQ: AMGN ) today announced ... president of Gladstone Institutes and Gladstone,s Robert W. and ... are pleased to welcome Dr. Sandy Williams ... , chairman and chief executive officer of Amgen. "Dr. ... his direct experience in our industry will both be ...
(Date:10/17/2014)... , Oct. 17, 2014 Research ... "Research and Development Prospect of China Dialysis ... Based on the 2013 version, this ... policies about dialysis industry and the relevant effect ... about dialysis industry segmentations. Moreover, it analyzes Chinese ...
Breaking Medicine Technology:Early Key Findings from the Medical Affairs Consortium Research 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 2Amgen Announces Appointment Of R. Sanders Williams To Board Of Directors 3Research and Development Prospect of China Dialysis Market, 2014-2018 2Research and Development Prospect of China Dialysis Market, 2014-2018 3
... Incorporated (Nasdaq: ARAY ), a global leader in ... fourth quarter and fiscal year 2010, ended June 30, 2010. ... Accuray reported total revenue of $61.8 million, a 5.1 percent ... of $58.8 million. For the fiscal year ended June 30, ...
... 31 Reportlinker.com announces that a new market ... The Global Orthobiologics Market - Players, ... http://www.reportlinker.com/p0192725/The-Global-Orthobiologics-Market---Players-products-and-technologies-driving-change-2008.html The primary ... factors compared with allograft bone tissue is that ...
Cached Medicine Technology:Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 2Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 3Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 4Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 5Accuray Announces Results for Fourth Quarter and Fiscal Year 2010 6Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008 2Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008 3Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008 4Reportlinker Adds The Global Orthobiologics Market - Players, products and technologies driving change 2008 5
(Date:10/20/2014)... 20, 2014 National Teen Driver Safety Week ... American Academy of Pediatrics (Ohio AAP, http://www.ohioaap.org ) is ... parents of teen drivers to talk to their teens and ... Motor vehicle crashes are the leading cause of death for ... in fatal crashes, and 859 (42%) of those teen drivers ...
(Date:10/20/2014)... Punzoné , the first line of ultra-premium organic ... to celebrate this month. October marks Italian Heritage Month – ... of Americans of Italian heritage and Italians in America. October ... its favorite Italian cocktails and encourages everyone to enjoy its ... it is only in a glass. , Punzoné continues ...
(Date:10/19/2014)... The leading review website, Top10BestSEOHosting.com, has recently announced ... the best Dedicated Server Hosting suppliers. Their websites ... buy high quality hosting and save money at ... Top10BestSEOHosting.com says, “We believe that iPage and GreenGeeks ... lot of the global clients enjoy using their ...
(Date:10/19/2014)... Having been working in the garment industry for ... needs. According to James, one of the company’s top designers, ... with high-low skirts that add beauty to them. Chiffon floor ... has unveiled its new selection of 2014 long prom dresses. ... new items are available in over 20 popular designs. The ...
(Date:10/19/2014)... Visual Impact Frequency Training - a ... to the public generating a frenzied buzz of ... community. The commotion surrounding the program's launch has ... an investigative review. , "Many gym-goers are familiar ... known as a training 'plateau' where they are ...
Breaking Medicine News(10 mins):Health News:Ohio AAP Promotes National Teen Driver Safety Week 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 2Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 3Health News:Celebrate Italian Heritage Month With Authentic Cocktails from Punzoné: The Only Ultra Premium Line of Organic Imported Italian Vodka 4Health News:Top10BestSEOHosting.com Considers iPage And GreenGeeks As The Best Dedicated Server Hosting Suppliers 2Health News:2014 Long Prom Dresses From LunaDress Now Available In Over 20 Popular Designs 2Health News:Visual Impact Frequency Training Review: Rusty Moore's Latest Fitness Guide Released 2
... in Turkey leads to pajamas offering a solution to troublesome ... ... do night sweats and a summer in,Turkey have in common? For 49-year-old ... a business,manufacturing and designing a line of night sweat sleepwear called,Cool-jams., , ...
... notes and restructures balance sheet eliminating $21.5 million of Redeemable ... ... Inc.,("CTI" or the "Company") (Nasdaq: CTIC ; MTA) today announced that ... due 2012 and warrants to purchase 7,326,950 shares of common,stock, no par ...
... When national drug use trends among adolescents go up or ... also goes up or down. Among deviance-prone female youth, it ... of Prevention Science., The risk of marijuana use among deviance-prone ... use among adolescents. The risk among deviance prone girls, however, ...
... HORIZON? , Children with allergic asthma may benefit from ... that trigger asthma and, in turn, decrease asthma symptoms ... University of Genoa in Italy reviewed the results of ... involving sublingual immunotherapy (SLIT) for allergic asthma in children. ...
... Adults without,symptoms of chronic obstructive pulmonary disease (COPD) should ... a new,recommendation from the U.S. Preventive Services Task Force. ... online,in the Annals of Internal Medicine. It will appear ... COPD is a lung disease in which the ...
... pediatric obesity epidemic in U.S. , , MONDAY, March 3 (HealthDay ... reduced the amount of food they ate and helped them ... hope to the problem of childhood obesity in the United ... to 19 years old are overweight, a 45 percent increase ...
Cached Medicine News:Health News:Photo: Sweet Dreams From Turkey 2Health News:Photo: Sweet Dreams From Turkey 3Health News:Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes 2Health News:Cell Therapeutics, Inc. Announces Issuance of $51.7 Million of New 2012 Convertible Senior Notes 3Health News:Drug use trends affect risk of marijuana in deviance prone boys, but not girls 2Health News:Journal Chest -- March 2008 news briefs 2Health News:Journal Chest -- March 2008 news briefs 3Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 2Health News:Task Force Recommends Against Screening for Chronic Obstructive Pulmonary Disease Using Spirometry 3Health News:Restricting TV and Computer Time Helps Kids Lose Weight 2
... MODULITH SLX is not only one of the ... versatile medical workstation. Apart from being designed for ... in the urinary tract, the MODULITH SLX can ... endourological therapies. It is equally suitable for the ...
... is designed to easily couple with ... coupling eliminates clumsy time consuming delays. ... well. Dorniers patented isocentric locating arm ... simple using the Dornier Relax+ table, ...
... and transportable, the Dornier Compact Delta lithotripsy system ... the patient. The systems shock source and C-arm ... and avoid the risk of misalignment. The therapy ... to its motorized lateral and horizontal movement and ...
Used for male external catheterization due to urinary incontinence. The inflatable retention ring secures the catheter and can be easily deflated for removal. Supplied non-sterile. Reusable. Intended...
Medicine Products: